参考文献/References:
[1].胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要[J]. 中国循环杂志,2019,34(3): 210-216.
[2].Foy AJ,Dhruva SS,Peterson B,et al. Coronary computed tomography angiography vs functional stress testing for patients with suspected coronary artery disease:a systematic review and meta-analysis[J]. JAMA Intern Med,2017,177(11):1623-1631.
[3].Levine GN,Bates ER,Blankenship JC,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. Catheter Cardiovasc Interv,2012,79(3):453-595.
[4].Tonino AL,de Bruyne B,Pijls N H,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention[J]. N Engl J Med,2009,360(3):213-224.
[5].de Bruyne B,Fearon WF,Pijls N H,et al. Fractional flow reserve-guided PCI for stable coronary artery disease[J]. N Engl J Med,2014,371(13):1208-1217.
[6].Xaplanteris P,Fournier S,Pijls NHJ,et al. Five-year outcomes with PCI guided by fractional flow reserve[J]. N Engl J Med,2018,379(3):250-259.
[7].G?tberg M,Cook CM,Sen S,et al. The evolving future of instantaneous?wave-free ratio and fractional flow?reserve[J]. J Am Coll Cardiol,2017,7 0(11):1379-1402.
[8].Jeremias A,Kirtane AJ,Stone GW. A test in context:fractional flow reserve:accuracy,prognostic implications,and?limitations[J]. J Am Coll Cardiol,2017,69 (22):2748-2758.
[9].Davies JE,Sen S,Dehbi HM,et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI[J]. N Engl J Med,2017,37 6(19):1824-1834.
[10].de Bruyne B,Pijls N H,Kalesan B,et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease[J]. N Engl J Med,2012,367(11):991-1001.
[11].Neumann FJ,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. Eur Heart J,2019,40(2):87-165.
[12].Levine GN,Bates ER,Blankenship JC,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. J Am Coll Cardiol,2011,58(24):e44-e122.
[13].Tu S,Echavarria-Pinto M,von Birgelen C,et al. Fractional flow reserve and coronary bifurcation anatomy:a novel quantitative model to assess and report the stenosis?severity of bifurcation lesions[J]. JACC Cardiovasc Interv,2015,8 (4):564-574.
[14].Tu S,Westra J,Yang J ,et al. Diagnostic accuracy of fast computational approaches to derive?fractional flow reserve from?diagnostic coronary angiography:the international multicenter FAVOR Pilot study[J]. JACC Cardiovasc Interv,2016,9 (19):2024-2035.
[15].Xu B,Tu S,Qiao S,et al. Diagnostic accuracy of angiography-based quantitative flow?ratio measurements for online assessment?of coronary stenosis[J]. J Am Coll Cardiol,2017,70(25):3077-3087.
[16].Westra J,Andersen BK,Campo G,et al. Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve:the FAVORⅡ Europe-Japan study[J]. J Am Heart Assoc,2018, 7(14):e009603.
[17].Westra J,Tu S,Campo G,et al. Diagnostic performance of quantitative flow ratio in prospectively enrolled patients:an individual patient-data meta-analysis.[J]. Catheter Cardiovasc Interv,2019,94(5):693-701.
[18].Emori H,Kubo T,Kameyama T,et al. Diagnostic accuracy of quantitative flow ratio for assessing myocardial ischemia in prior myocardial infarction[J]. Circ J,2018,82(3):807-814.
[19].Lauri FM,Macaya F,Mejía-Rentería H,et al. Angiography-derived functional assessment of non-culprit coronary stenoses in primary percutaneous coronary intervention[J]. EuroIntervention,2020,15(18):e1594-e1601.
[20].Smit JM,El Mahdiu M,van Rosendael AR,et al. Comparison of diagnostic performance of quantitative flow ratio in patients with versus without diabetes mellitus[J]. Am J Cardiol,2019,123 (10):1722-1728.
[21].Liontou C,Mejía-Rentería H,Lauri F,et al. Functional assessment of in-stent restenosis with quantitative flow ratio[J]. EuroIntervention,2019,Jul 30:EIJ-D-18-00955.DOI:10.4244/EIJ-D-18-00955.
[22].Spitaleri G,Tebaldi M,Biscaglia S,et al. Quantitative flow ratio identifies nonculprit coronary lesions requiring revascularization in patients with ST-segment-elevation myocardial infarction and multivessel disease[J]. Circ Cardiovasc Interv,2018,11 (2):e006023.
[23].Rubimbura V,Guillon B,Fournier S,et al. Quantitative flow ratio virtual stenting and post stenting correlations to post stenting fractional flow reserve measurements from the DOCTORS (Does Optical Coherence Tomography Optimize Results of Stenting) study population[J]. Catheter Cardiovasc Interv,2019,96(6):1145-1153.
[24].Sheng X,Qiao Z,Ge H,et al. Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction[J]. Catheter Cardiovasc Interv,2020, 95 suppl 1:624-632.
[25].Qi Q,Liu G,Yuan Z,et al. Quantitative flow ratio-guided surgical intervention in symptomatic myocardial bridging[J]. Cardiol J,2020,27(6):685-692.
[26].Biscaglia S,Tebaldi M,Brugaletta S,et al. Prognostic value of QFR measured immediately after successful stent implantation:the international multicenter prospective HAWKEYE study[J]. JACC Cardiovasc Interv,2019,12 (20):2079-2088.
[27].Kogame N,Takahashi K,Tomaniak M,et al. Clinical implication of quantitative flow ratio after percutaneous coronary intervention for 3-vessel disease[J]. JACC Cardiovasc Interv,2019,12(20):2064-2075.
[28].Hamaya R,Hoshino M,Kanno Y,et al. Prognostic implication of three-vessel contrast-flow quantitative flow ratio in patients with stable coronary artery disease[J]. EuroIntervention,2019,15 (2):180-188.
[29].Buono A,Mühlenhaus A,Sch?fer T,et al. QFR predicts the incidence of long-term adverse events in patients with suspected CAD:feasibility and reproducibility of the method[J]. J Clin Med,2020,9 (1):220.
[30].Asano T,Katagiri Y,Chang CC,et al. Angiography-derived fractional flow reserve in the SYNTAXⅡtrial:feasibility,diagnostic performance of quantitative flow ratio,and clinical prognostic value of functional SYNTAX score derived from quantitative flow ratio in patients with 3-vessel disease[J]. JACC Cardiovasc Interv,2019,12 (3):259-270.
[31].Tang J,Lai Y,Tu S,et al. Quantitative flow ratio guided residual functional SYNTAX score for risk assessment in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention[J]. EuroIntervention,2019 ,Oct 8:EIJ-D-19-00369.DOI:10.4244/EIJ-D-19-00369.
[32].Tanigaki T,Emori H,Kawase Y,et al. QFR versus FFR derived from computed?tomography for functional?assessment of coronary?artery stenosis[J]. JACC Cardiovasc Interv,2019,12(20):2050-2059.
[33].Kogame N,Ono M,Kawashima H,et al. The Impact of coronary physiology on contemporary clinical decision making[J]. JACC Cardiovasc Interv,2020,13 (14):1617-1638.
[34].Mejía-Rentería H,Lee JM,Lauri F,et al. Influence of microcirculatory dysfunction on angiography-based functional assessment of coronary stenoses[J]. JACC Cardiovasc Interv,2018,11 (8):741-753.
[35].Xu B,Tu S,Qiao S,et al. Diagnostic accuracy of angiography-based quantitative flow ratio measurements for online assessment of coronary stenosis[J]. J Am Coll Cardiol,2017,70(25):3077-3087.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(7):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(7):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(7):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(7):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(7):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(7):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(7):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(7):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(7):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]